Showing posts with label Insights. Show all posts
Showing posts with label Insights. Show all posts

Tuesday, 4 November 2014

Reports and Intelligence: Global human insulin market during 2013-2020

Human insulin is used to regulate glucose metabolism in the human body.  It also helps in regulating carbohydrate and fat metabolism in people with diabetes. With the growing incidence of diabetes across the globe, insulin is a much needed glucose regulating method for the patients.

Reports and Intelligence adds a report titled “Global Human Insulin Market (Product Type, Brand and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020.” The report states that the global human insulin market is expected to witness a significant growth rate during the forecast period.


The report examines the global market through various segments such as types, brands, technologies, geographies and competitive landscape. It also provides deep insights of the global market by analyzing market trends and various factors influencing the growth of the market.

The growing number of obesity cases, changing lifestyle, geriatric population and inadequate healthcare conditions in many regions are leading to the growth of diabetes. The growing number of diabetic patients is fuelling the growth of the global human insulin market. Also, technological advancements such as insulin pens and many more coming up would propel the growth of the global market.

The report segment on the product type mainly includes modern and traditional types of human insulin. Traditional human insulin segment consists of Intermediate Acting, Premixed and Short Acting types of Human Insulin. Modern human insulin types includes Long Acting, Rapid Acting Premixed types of human insulin. The efficiency of the modern human insulin is making it a preferred choice by the end users. Long acting and premixed modern insulin are the main types of human insulin that are expected to grow rapidly during the forecast period.

As per the report, Asia-Pacific and LAMEA are the fastest growing geographical regions with large number of diabetic patients, improving healthcare conditions and favorable government regulations.  Other geographical regions included in the report are North America and Europe, out of which North America would dominate the global human insulin market in terms of revenue.

The report would provide the market investors with comprehensive knowledge of the global market and competitive scenario at the global level. It provides extensive information of the developmental strategies adopted by the global players and technological advancements in the field of human insulin market.

Report profiles the following companies from the global market:                
          Eli Lilly
          GlaxoSmithCline
          Biocon
          Sanofi Aventis
          Julphar
          Novo Nordisk
          SemBioSys
          Wockhardt

Monday, 20 October 2014

Reports and Intelligence: Aesthetic procedures are the growing trend leading the growth of skin-care device market

Skin care devices assist in treating skin cancer and many skin-related diseases & disorders such as dermatitis, acne, psoriasis, moles, warts and lesions. Medical Spas, also known as ‘Medspas’, is a growing trend today across the globe. Also, the growing trend for skin rejuvenation, body contouring, skin tightening and liposuction has raised the numbers for skin care devices across the globe.


Reports and Intelligence adds a report titled “Global Skincare Devices Market (Types, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020.” The report provides in-depth analysis of the global skin-care devices market.

The report explains each and every facet of the skin care devices market in various regions across the globe. The report is designed with an aim to provide businesses with deep market insights and opportunities for the skin care devices market, globally. The report consists of inputs from the industry experts in order to provide market investors with a better understanding of various market dynamics.

With the rising incidences of skin-related diseases, technological advancements and the growing trend of aesthetic skin related procedures among consumers are some of the major factors driving the growth of the global market. However, the high cost involved in procuring equipment and high cost of treatmentshold the market growth in many developing regions.

The report provides deep knowledge of the various segments of the global skin care devices market. The various segments include types, treatments &applications and geography. The report provides holistic information and a wide range of statistical data from various geographies such as Europe, North America, Asia-Pacific and LAMEA. As per the report, North America would be the largest revenue generating sector;whereas, due tothe increasing disposable income and consumer expansion, Asia-Pacific is expected to be fastest growing market for skin-care devices.Treatment wise, LED therapy dominates the other types of treatment for skin issues, holding the largest revenue share.

Leading global players profiled in the report are Cutera Inc., Alma Lasers, Ltd., Cynosure Inc., Michelson Diagnostics Ltd., Lumenis Ltd., Palomar Medical Technologies, Solta Medical, Inc., Photomedex Inc. and Syneron Medical Ltd.